Genentech extends buyback program by $2 billion

Genentech (NYSE: DNA) announced a $2 billion extension of its current $6 billion stock repurchase program that is authorized through June 2008.

The board kept the program limited to a total of 100 million shares, of which, the company had completed the repurchase of 67 million shares through March 2007.

###

PAYOUT YIELD ANALYSIS

Because the purpose of the program is to offset dilution from employee stock plans, we are not projecting a Payout Yield to shareholders from the current buyback program.

- Payout Yield Staff

Subscribe

Subscribe to our e-mail newsletter to receive updates.